According to SEC filings for the period ending September 2025, Keros Therapeutics, Inc. (NASDAQ:KROS) is held by 154 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 30 Sep, 2025 | 5,389,264 | 0 | 0.00% | $85,258,156.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 2,718,777 | 87,129 | 3.31% | $43,011,052.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 2,717,153 | -15,470 | -0.57% | $42,985,352.00 |
| Madison Avenue Partners, LP | 30 Sep, 2025 | 2,708,218 | 16,753 | 0.62% | $42,844,009.00 |
| Western Standard LLC | 30 Sep, 2025 | 2,189,882 | 654,989 | 42.67% | $34,643,933.00 |
| TANG CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 1,418,984 | 0 | 0.00% | $22,448,327.00 |
| D. E. Shaw & Co., Inc. | 30 Sep, 2025 | 1,331,425 | 34,042 | 2.62% | $21,063,144.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 1,325,483 | 441,923 | 50.02% | $20,969,141.00 |
| STATE STREET CORP | 30 Sep, 2025 | 1,302,978 | -81,276 | -5.87% | $20,613,112.00 |
| Nantahala Capital Management, LLC | 30 Sep, 2025 | 1,233,189 | -387,503 | -23.91% | $19,509,050.00 |
| ORBIMED ADVISORS LLC | 30 Sep, 2025 | 1,018,734 | 0 | 0.00% | $16,116,372.00 |
| ALKEON CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 850,511 | 0 | 0.00% | $13,455,084.00 |
| Logos Global Management LP | 30 Sep, 2025 | 850,000 | -1,150,000 | -57.50% | $13,447,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 837,363 | 8,066 | 0.97% | $13,249,727.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 30 Sep, 2025 | 607,089 | 82,749 | 15.78% | $9,604,148.00 |
| Redmile Group, LLC | 30 Sep, 2025 | 552,506 | 0 | 0.00% | $8,740,645.00 |
| FEDERATED HERMES, INC. | 30 Sep, 2025 | 514,160 | -139,870 | -21.39% | $8,134,011.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 395,103 | -483,643 | -55.04% | $6,250,537.00 |
| Connor, Clark & Lunn Investment Management Ltd. | 30 Sep, 2025 | 335,154 | 69,447 | 26.14% | $5,302,136.00 |
| PDT Partners, LLC | 30 Sep, 2025 | 332,815 | 0 | 0.00% | $5,265,133.00 |